← Back
Data updated: Mar 10, 2026
ELORAC
OncologyDermatology
ELORAC is a pharmaceutical company focused on Oncology, Dermatology.
1970
Since
1
Drugs
-
Trials
0
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
No recent activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 67%
0 drugs Phase 3: 1
Dermatology 33%
0 drugs Phase 2: 1
Pipeline Strength Pro
Loading...
Active (0)
Discontinued (1)
Company Info
- First Approval
- 1970-07-31
- Latest
- 1998-11-30
- Applications
- 1